Attached files

file filename
EX-32.1 - EXHIBIT 32.1 SECTION 906 CERTIFICATION - SweeGen, Inc.f10qa123116_ex32z1.htm
EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - SweeGen, Inc.f10qa123116_ex31z1.htm


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10–Q/A

(Amendment No. 1)


(Mark One)

  X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended December 31, 2016


or


      . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from ____________ to ________________


Commission file number: 333-190547


SweeGen, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Nevada

 

80-0910515

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

30321 Esperanza Avenue, Rancho Santa Margarita, CA 92688

(Address of principal executive offices)

 

949-709-0583

(Registrant's telephone number, including area code)

 

Aceway Corp., 2620 Regatta Drive, Ste. 102, Las Vegas, Nevada 89128

(Former name, former address and former fiscal year, if changed since last report)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  X . No      .


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  X . No      .


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act (Check one).


Large accelerated filer      .

 

Accelerated filer      .

 

 

 

Non-accelerated filer      .

 

Smaller reporting company  X .

(Do not check if a smaller reporting company)

 

 


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      . No  X .


As of February 14, 2017, there are 25,503,453 shares of the issuer's common stock, par value $0.001, outstanding.






EXPLANATORY NOTE


This Amendment No. 1 on Form 10-Q (“Amendment No. 1”) is an amendment to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, filed with the Securities and Exchange Commission on February 14, 2017 (the “Original Filing Date”), solely to furnish Exhibit 101 to the Form 10-Q. Exhibit 101 consists of the following materials filed with the Company’s Form 10-Q, formatted in XBRL (eXtensible Business Reporting Language):


101.INS XBRL Instance Document**

101.SCH XBRL Taxonomy Extension Schema Document**

101.CAL XBRL Taxonomy Calculation Linkbase Document**

101.DEF XBRL Taxonomy Definition Linkbase Document**

101.LAB XBRL Taxonomy Label Linkbase Document**

101.PRE XBRL Taxonomy Presentation Linkbase Document**


**

Filed herewith by amendment


This Amendment No. 1 speaks as of the Original Filing Date, does not reflect events that may have occurred subsequent to the Original Filing Date, and does not modify or update in any way disclosures made in the Form 10-Q.




2




PART II – OTHER INFORMATION


Item 6. Exhibits.


The following exhibits are included as part of this report:


Exhibit No.

Description


10.1

Distribution Agreement by and between SweeGen, Inc. and Ingredion Incorporated, dated as of November 28, 2016*

10.2

Inter-Company Patent License Agreement by and between Conagen Inc. and SweeGen, Inc., dated as of November 28, 2016*

31.1

Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive and Financial Officer**

32.1

Rule 1350 Certification of Principal Executive and Financial Officer**

101.INS

XBRL Instance**

101.SCH

XBRL Taxonomy Extension Schema**

101.CAL

XBRL Taxonomy Extension Calculations**

101.DEF

XBRL Taxonomy Extension Definitions**

101.LAB

XBRL Taxonomy Extension Labels**

101.PRE

XBRL Taxonomy Extension Presentation**



* Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. Omitted material for which confidential treatment has been requested has been filed separately with the Securities and Exchange Commission.


** Filed herewith by amendment.



3




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 

SWEEGEN, INC.

 

(Registrant)

 

 

 

 

Dated: February 15, 2017

/s/ Steven Chen

 

Steven Chen

 

Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Director

 

(Principal Executive, Financial, and Accounting Officer)

 

 





4